Impact Analysis of Covid-19
The complete version of the Report will include the impact of the COVID-19, and anticipated change on the future outlook of the industry, by taking into the account the political, economic, social, and technological parameters.
3D cell culture is an artificially created environment. 3D cell culture is a culture environment that allows biological cells to interact with their surroundings in all three dimensions. Cells grown in 3D cell culture exhibit similar properties of cells found in living organisms, in terms of cellular characteristics and behavior. This technique allows the cells to grow in their natural environment in an in vivo condition.
The global 3D cell culture market is estimated to be valued at US$ 2,604.3 million in 2020 and is expected to exhibit a CAGR of 23.4% during the forecast period (2020-2027).
Figure 1.Global 3D Cell Culture Market Share (%) in Terms of Value, By Technology 2020
Increasing product launches by key companies are expected to drive the market growth during the forecast period.
The increasing product launches of 3D cell cultures by regulatory authorities and key players, respectively are expected to drive the market growth over the forecast period. For instance, in January 2021, Jellagen Limited, a biotechnology company manufacturing high value Collagen Type 0 derived from jellyfish, announced the launch of JellaGel Hydrogel. 3-dimensaional hydrogels allow cells to grow and interact with all of its surroundings. Cells grown in a 3D model have proven to be more natural, with improved cell viability, morphology, proliferation, and differentiation.
Figure 2.Global 3D Cell Culture Market Share (%), by Application, 2020
Increasing R&D activities in 3D cell culture is expected to drive the market growth during the forecast period.
The increasing R&D activities in 3D cell culture is expected to aid in growth of the global 3D cell culture market, over the forecast period. For instance, in August 2020, researchers at Okayama University created a new 3D cell culture model of pancreatic cancer that closely mimics the 'fibrotic' tissue characteristically observed in patients.
3D Cell Culture Market Report Coverage
||Market Size in 2020:
||US$ 2,604.3 Mn
|Historical Data for:
||2016 to 2019
||2020 to 2027
|Forecast Period 2020 to 2027 CAGR:
||2027 Value Projection:
||US$ 11,335.1 Mn
- North America: U.S., and Canada
- Latin America: Brazil, Argentina, Mexico, and Rest of Latin America
- Europe: Germany, U.K., Spain, France, Italy, Russia, and Rest of Europe
- Asia Pacific: China, India, Japan, Australia, South Korea, ASEAN, and Rest of Asia Pacific
- Middle East: GCC Countries, Israel, and Rest of Middle East
- Africa: South Africa, North Africa, and Central Africa
- By Technology: Extracellular Matrices or Scaffolds, Bioreactors, Gels, Scaffold-free Platforms, Microchips
- By Application: Research, Drug Discovery, Tissue Engineering, Clinical Applications, Stem Cell Biology
- By End User: Research Labs & Institutes, Biopharmaceutical Industry, Hospitals And Diagnostic Centers, Others
Becton, Dickinson and Company, Thermo Fisher Scientific Inc., Lonza, Merck KGaA, 3D Biotek LLC, 3D Biomatrix, Inc., 3D Biomatrix, Inc., and REPROCELL Inc.
- Increasing products approvals and launches
- Increasing R&D activities in 3D cell culture
- Rising prevalence of cancer and infectious diseases
|Restraints & Challenges:
- Lack of consistency in products such as Extracellular Matrices or Scaffolds
Global 3D Cell Culture Market – Impact of Coronavirus (COVID-19) Pandemic
The coronavirus (COVID-19) pandemic and lockdown in various countries across the globe has impacted the financial status of businesses in all sectors. The private healthcare is one of the sector, which has been majorly impacted by the pandemic. The lockdowns in various countries has created an economic burden on the private healthcare sector. Healthcare providers are facing challenges with regards to manpower, equipment, consumables, and other resources to ensure safety of patients with other diseases, and declining outpatient’s visits, among others. Moreover, the pandemic has negatively impacted the development, production, and supply of drugs, and affected growth of the healthcare segment of various companies across the globe. This has led to closure of industrial establishments, except manufacturing of essential commodities, and disruption in supply chain of products. The COVID-19 pandemic has affected the economy in three main ways; 1) by directly affecting the production and demand; 2) by creating disruptions in distribution channels; and 3) through its financial impact on companies and financial markets. Supply chain and manufacturing activities in India, China, U.S., and others have been disrupted due to global lockdowns. Whereas, countries such as Thailand, Indonesia, Singapore, and others are facing problems with transportation of drugs and medications. Thus, the pandemic is expected to slightly disrupt the R&D activities of the 3D cell culture market. However, currently the spread of coronavirus has spurred growth of 3D cell culture market, owing to increasing 3D cell culture for regeneration of 3D cell culture organs for understanding the mechanism of coronavirus infection.
Global 3D Cell Culture Market: Restraint
The major factors that hinder growth of the global 3D cell culture market include lack of consistency in 3D cell culture products. The lack of consistency between wells and batches of cell culture are the other major barriers in the adoption of 3D cell culture techniques. Researchers face several problems while inserting scaffold/ECM into microplate wells. This inconsistency in the products reduces the reproducibility of results and, thus, reduces the efficiency of the research.
Major players operating in the global 3D cell culture market include Becton, Dickinson and Company, Thermo Fisher Scientific Inc., Lonza, Merck KGaA, 3D Biotek LLC, 3D Biomatrix, Inc., 3D Biomatrix, Inc., and REPROCELL Inc.